血糖、血脂、胱抑素C及同型半胱氨酸联合检测冠心病的价值
The Value of Blood Glucose, Lipids, Cystatin C and Homocysteine in Combining to Detect Coronary Heart Disease
摘要: 目的:探讨血糖、血脂、胱抑素C及同型半胱氨酸联合检测对冠心病的诊断价值。方法:收集2020年1月~2022年1月来我院就诊的489例冠心病患者及480例健康人群的高血压史,血糖(GLU),肌酐(CRE),总蛋白(TP),甘油三酯(TG),总胆固醇(TC),高密度脂蛋白(HDL),低密度脂蛋白(LDL),脂蛋白a (Lp(a)),肌酸激酶(CK),乳酸脱氢酶(LDH),胱抑素C (CysC),腺苷脱氨酶(ADA),β羟丁酸(β-HB),游离脂肪酸(NEFA),视黄醇结合蛋白(RBP),总胆汁酸(TBA),同型半胱氨酸(HCY)和超敏C反应蛋白(hs-CRP)。单因素分析冠心病的可疑影响因素,二元logistic回归分析冠心病的独立危险因素并计算联合预测因子,并用受试者工作特征曲线(ROC)分析血糖、血脂、CysC、HCY及联合预测因子对冠心病的诊断价值。结果:经多因素二元Logistic回归分析显示血糖(OR = 1.257)、甘油三酯(OR = 1.724)、总胆固醇(OR = 1.458)、低密度脂蛋白(OR = 3.776)、Lp(a) (OR = 1.038)、胱抑素C (OR = 6.942)、游离脂肪酸(OR = 1.002)和同型半胱氨酸(OR = 1.304)是冠心病的独立危险因素,高密度脂蛋白(OR = 0.164)与冠心病的发生成负相关。Glu、TG、TC、LDL、Lp(a)、NEFA、CysC及HCY单独诊断的敏感度是0.63、0.481、0.776、0.578、0.401、0.438、0.414、0.889,特异度分别是0.619、0.81、0.583、0.692、0.875、0.794、0.954、0.637。联合预测因子的敏感度0.868,特异度0.85。结论:血糖、血脂、CysC及HCY联合预测冠心病有重要的意义,可推广用于临床。
Abstract: Objective: To explore the diagnostic value of combined detection of blood glucose, blood lipid, Cys-tatin C and homocysteine in coronary heart disease. Methods: A total of 489 patients with coronary heart disease and 480 patients in physical examination center from January 2020 to January 2022 were enrolled in this study, hypertension, fasting blood glucose (GLU), creatinine (CRE), total pro-tein (TP), triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL), low-density lipo-protein (LDL), lipoprotein (a) (Lp(a)), creatine kinase (CK), lactate dehydrogenase (LDH), cystatin C (CysC), adenosine deaminase (ADA), β-hydroxybutyric acid (β-HB), nonestesterified fatty acid (NEFA), retinol-binding protein (RBP), total bile acid (TBA), homocysteine (HCY) and high sensitivi-ty C-reactive protein (hs-CRP). Logistic regression analysis was used to analyze the independent risk factors of coronary heart disease and calculate the combined predictors. Receiver operating char-acteristic curve (ROC) was used to analyze the diagnostic value of blood glucose, blood lipid, CysC and Hcy for coronary heart disease. Results: Multivariate binary logistic regression analysis showed that blood glucose (OR = 1.257), triglyceride (OR = 1.724), total cholesterol (OR = 1.458), low-density lipoprotein (OR = 3.776), LP(a) (OR = 1.038), Cystatin C (OR = 6.942), nonestesterified fatty acid (OR = 1.002) and homocysteine (OR = 1.304) were independent risk factors for coronary heart disease, the corresponding sensitivities of which were 0.63, 0.481, 0.776, 0.578, 0.401, 0.438, 0.414 and 0.889, and the specificities were 0.619, 0.81, 0.583, 0.692, 0.875, 0.794, 0.954 and 0.637. The sensitivity and specificity of the combined predictors were 0.868 and 0.85. And high-density lipoprotein (OR = 0.164) was negatively correlated with coronary heart disease. Conclusion: The combination detection of blood glucose, blood lipid, CysC and Hcy has important significance in pre-dicting coronary heart disease, which can be widely used in clinic.
文章引用:张帅. 血糖、血脂、胱抑素C及同型半胱氨酸联合检测冠心病的价值[J]. 临床医学进展, 2022, 12(8): 7891-7897. https://doi.org/10.12677/ACM.2022.1281137

参考文献

[1] Lozano, R., Naghavi, M., Foreman, K., et al. (2012) Global and Regional Mortality from 235 Causes of Death for 20 Age Groups in 1990 and 2010: A Systematic Analysis for the Global Burden of Disease Study 2010. The Lancet (Lon-don, England), 380, 2095-2128. [Google Scholar] [CrossRef
[2] Terman, S.W., Aubert, C.E., Hill, C.E., et al. (2021) Cardiovascular Disease Risk, Awareness, and Treatment in People with Epilepsy. Epilepsy & Behavior, 117, Article ID: 107878. [Google Scholar] [CrossRef] [PubMed]
[3] Nichols, M., Townsend, N., Scarborough, P.J., et al. (2014) Cardiovascular Disease in Europe 2014: Epidemiological Update. European Heart Journal, 35, Article No. 2929. [Google Scholar] [CrossRef] [PubMed]
[4] Jahangiry, L., Najafi, M., Farhangi, M.A., et al. (2017) Coronary Artery Bypass Graft Surgery Outcomes Following 6.5 Years: A Nested Case-Control Study. International Journal of Preventive Medicine, 8, Article No. 23. [Google Scholar] [CrossRef
[5] 邱玲. 心电图及冠状动脉造影诊断冠心病价值比较[J]. 中国医疗设备, 2019, 34(S2): 184-186.
[6] 李萍, 惠品晶, 金琳, 等. 超声造影在动脉粥样硬化诊断中的研究进展[J]. 医学综述, 2020, 26(3): 139-143.
[7] Hoque, K.E., Ferdows, M., Sawall, S., et al. (2021) The Impact of Hemo-dynamic Factors in a Coronary Main Artery to Detect the Atherosclerotic Severity: Single and Multiple Sequential Steno-sis Cases. Physics of Fluids, 33, Article No. 13. [Google Scholar] [CrossRef
[8] Garshick, M.S., Vaidean, G., Vnai, A., et al. (2019) Cardiovascular Risk Factor Control and Lifestyle Factors in Young to Middle-Aged Adults with Newly Diagnosed Obstructive Coronary Artery Disease. Cardiology, 142, 83-90. [Google Scholar] [CrossRef] [PubMed]
[9] 邹优兰, 丁欣, 黄国伟, 等. 同型半胱氨酸, S-腺苷同型半胱氨酸及其联合检测对冠心病预测价值的探讨[J]. 军事医学, 2019, 43(9): 674-679.
[10] 张小红, 李艳华, 张晓丹. 心肌酶谱、Hcy、PCT联合检测对冠心病的诊断价值研究[J]. 中外医学研究, 2021, 19(10): 87-89.
[11] 李海波, 那曼丽, 张滨, 等. 冠状动脉CTA对冠状动脉粥样硬化性心脏病高危人群的随访观察价值[J]. 中国医学影响技术, 2018, 14(4): 518-522.
[12] 肖日国, 许晓杰. 双源CT测量心周脂肪体积联合血尿酸、同型半胱氨酸监测对冠心病早期诊断的价值分析[J]. 中国CT和MRI杂志, 2020, 18(1): 54-56.
[13] Jenkins, D.A., et al. (2021) Estimating the Causal Effect of BMI on Mortality Risk in People with Heart Disease, Diabetes and Cancer Using Mendelian Randomi-zation. International Journal of Cardiology, 330, 214-220. [Google Scholar] [CrossRef] [PubMed]
[14] Burgess, S., et al. (2021) Dose-Response Relationship between Genetically Proxied Average Blood Glucose Levels and Incident Coronary Heart Disease in Individuals without Diabetes Mellitus. Diabetologia, 64, 845-849. [Google Scholar] [CrossRef] [PubMed]
[15] Goda, Y., Mori, H., Kobara, H., et al. (2018) Efficacy of Suffi-cient Operation View by Ring-Shaped Thread Counter Traction for Safer Duodenal ESD. Minimally Invasive Therapy & Allied Technologies, 27, 327-332. [Google Scholar] [CrossRef] [PubMed]
[16] Li, C., Chen, Q., Zhang, M., Liu, Y., Chu, Y., Meng, F., Wang, J., Tang, J., Luo, J., Niu, X. and Wei, M. (2021) The Correlation between Lipoprotein(a) and Coronary Athero-sclerotic Lesion Is Stronger than LDL-C, when LDL-C Is Less than 104 mg/dL. BMC Cardiovascular Disorders, 21, Article No. 41. [Google Scholar] [CrossRef] [PubMed]
[17] 袁志华, 丁琪, 靳松, 等. 脂蛋白(a)与心血管疾病风险[J]. 中华临床医师杂志: 电子版, 2016, 10(15): 2341-2344.
[18] Li, W., Sultana, N., Siraj, N., et al. (2016) Autophagy Dysfunction and Regulatory Cystatin C in Macrophage Death of Atherosclerosis. Journal of Cellular and Molecular Medicine, 20, 1664-1672. [Google Scholar] [CrossRef] [PubMed]
[19] Otsuka, T., Kato, K., Kachi, Y., et al. (2014) Serum Cystatin C, Creatinine-Based Estimated Glomerular Filtration Rate, and the Risk of Incident Hypertension in Mid-dle-Aged Men. American Journal of Hypertension, 27, 596-602. [Google Scholar] [CrossRef] [PubMed]
[20] Gonçalves-de-Albuquerquem, C.F., et al. (2019) Serum Albumin Satura-tion Test Based on Non-Esterified Fatty Acids Imbalance for Clinical Employment. Clinica Chimica Acta, 495, 422-428. [Google Scholar] [CrossRef] [PubMed]
[21] Son, P. and Lewis, L. (2021) Hyperhomocysteinemia. In: StatPearls [Internet], StatPearls Publishing, Treasure Island.
[22] Li, S., Sun, L., Qi, L., et al. (2020) Effect of High Homocysteine Level on the Severity of Coronary Heart Disease and Prognosis after Stent Implantation. Journal of Cardiovascular Pharmacology, 76, 101-105. [Google Scholar] [CrossRef
[23] 邹优兰, 胡汉, 吕欣, 陈永杰, 于向东, 董邵壮, 王清, 李永乐, 王蓓, 丁欣, 黄国伟, 高玉霞. 同型半胱氨酸、S-腺苷同型半胱氨酸及其联合检测对冠心病预测价值的探讨[J]. 军事医学, 2019, 43(9): 674-679.